These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 24003079)
21. Ethnic comparisons of disease severity in children hospitalized with pneumonia in New Zealand. Grant CC; Pati A; Tan D; Vogel S; Aickin R; Scragg R J Paediatr Child Health; 2001 Feb; 37(1):32-7. PubMed ID: 11168866 [TBL] [Abstract][Full Text] [Related]
22. Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome. Sahin S; Adrovic A; Barut K; Canpolat N; Ozluk Y; Kilicaslan I; Caliskan S; Sever L; Kasapcopur O Lupus; 2018 Mar; 27(3):514-519. PubMed ID: 29233038 [TBL] [Abstract][Full Text] [Related]
23. Incidence of cancer among Pacific Island people in New Zealand. Tukuitonga CF; Solomon N; Stewart A N Z Med J; 1992 Nov; 105(946):463-6. PubMed ID: 1436871 [TBL] [Abstract][Full Text] [Related]
24. Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patients. Cavalcante EG; Aikawa NE; Lozano RG; Lotito AP; Jesus AA; Silva CA Lupus; 2011 Aug; 20(9):960-4. PubMed ID: 21636626 [TBL] [Abstract][Full Text] [Related]
25. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Marks SD; Pilkington C; Woo P; Dillon MJ Rheumatology (Oxford); 2004 Sep; 43(9):1186-9. PubMed ID: 15226518 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance and clinical associations of antibodies to the chromatin antigenic system in juvenile systemic lupus erythematosus. Keusseyan SP; da Silva NP; Hilário MO; Okuda EM; Terreri MT; Andrade LE Rev Bras Reumatol; 2012 Oct; 52(5):695-712. PubMed ID: 23090370 [TBL] [Abstract][Full Text] [Related]
27. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Brunner HI; Feldman BM; Bombardier C; Silverman ED Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262 [TBL] [Abstract][Full Text] [Related]
28. Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey. Balci S; Ekinci RMK; Bayazit AK; Melek E; Dogruel D; Altintas DU; Yilmaz M Clin Rheumatol; 2019 May; 38(5):1459-1468. PubMed ID: 30648229 [TBL] [Abstract][Full Text] [Related]
29. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471 [TBL] [Abstract][Full Text] [Related]
30. Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study. Smith EM; Foster HE; Gray WK; Taylor-Robinson D; Beresford MW; Rheumatology (Oxford); 2014 Mar; 53(3):557-61. PubMed ID: 24310297 [TBL] [Abstract][Full Text] [Related]
31. Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients. Mosaad NA; Lotfy HM; Farag YM; Mahfouz RH; Shahin RM Immunol Lett; 2017 Jan; 181():16-19. PubMed ID: 27838471 [TBL] [Abstract][Full Text] [Related]
32. Does mortality vary between pacific groups in New Zealand? Estimating Samoan, Cook Island Maori, Tongan, and Niuean mortality rates using hierarchical Bayesian modelling. Blakely T; Richardson K; Young J; Callister P; Didham R N Z Med J; 2009 Dec; 122(1307):18-29. PubMed ID: 20148041 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology of acute rheumatic fever in New Zealand 1996-2005. Jaine R; Baker M; Venugopal K J Paediatr Child Health; 2008 Oct; 44(10):564-71. PubMed ID: 19012628 [TBL] [Abstract][Full Text] [Related]
34. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials. Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW; Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628 [TBL] [Abstract][Full Text] [Related]
35. Reduced expressions of Fas and Bcl-2 proteins in CD14+ monocytes and normal CD14 soluble levels in juvenile systemic lupus erythematosus. Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C Lupus; 2013 Aug; 22(9):940-7. PubMed ID: 23846229 [TBL] [Abstract][Full Text] [Related]
36. Incidence and prevalence of systemic lupus erythematosus in New Zealand from the national administrative datasets. Lao C; White D; Rabindranath K; Van Dantzig P; Foxall D; Aporosa A; Lawrenson R Lupus; 2023 Jul; 32(8):1019-1027. PubMed ID: 37268603 [TBL] [Abstract][Full Text] [Related]
37. Ethnicity of severe trauma patients: results of a population-based study, Auckland, New Zealand 2004. Creamer G; Civil I; Ng A; Adams D; Cacala S; Koelmeyer T; Thompson J N Z Med J; 2010 Jun; 123(1316):26-32. PubMed ID: 20648097 [TBL] [Abstract][Full Text] [Related]
38. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus. Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099 [TBL] [Abstract][Full Text] [Related]
39. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus. Sato JO; Corrente JE; Saad-Magalhães C Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556 [TBL] [Abstract][Full Text] [Related]